Anthony W. Tolcher

Dr. Anthony W. Tolcher, MD, is CEO, founder, and Director of Clinical Research at NEXT Oncology in San Antonio, Texas, a phase 1 program with the mission to accelerate the development of the next breakthrough cure for cancer through high-quality Phase 1 clinical and clinical pharmacology trials. In this function, Dr. Tolcher is coordinating and supervises clinical trials with novel targeted cancer therapies.

Dr. Tolcher is a board-certified Medical Oncologist with an MD degree from the University of British Columbia, Vancouver, Canada. Dr. Tolcher specialized in Internal Medicine and Medical Oncology in residency programs at the University of Toronto and again at the University of British Columbia, respectively, before engaging in oncology research at the National Cancer Institute (NCI), the National Institutes of Health (NIH) in Bethesda. He held a staff position at the British Columbia Cancer Agency in Vancouver before moving to the Institute for Drug Development, Cancer Therapy and Research Center University of Texas Health Science Center in San Antonio where he became Director of Clinical Research in 1999, a position he held for almost 10 years.